This was the stock's second consecutive day of gains.

Raymond James is seeing a beneficial shift to advisory as well as recovering M&A activity, which may continue. Read why I ...

Yes, again. As fragile as Oklahoma County's finances are, another misstep with Moody's Ratings, a missed deadline, could make ...

The world's two biggest economies are on the brink of an economically destructive trade war. Here's what experts think could ...

Shares of Raymond James Financial Inc. RJF slipped 1.27% to $168.48 Friday, on what proved to be an all-around dismal trading ...

Following similar moves by other large firms, Raymond James says quarterly advisor counts aren’t the most meaningful measure ...

LPL Financial welcomes a $345 million investment and planning team from Ameriprise as RayJay's employee advisor arm adds a ...

Plans for new tariffs on Canada and China and Mexico sent stocks falling early Monday. Even as markets recover, experts say ...

James initiated coverage on Regenxbio Inc . (NASDAQ:RGNX), bestowing an Outperform rating and setting a price target of $27.00 for the biotechnology company's shares. The firm's endorsement comes with ...

Fintel reports that on February 6, 2025, Raymond James downgraded their outlook for Symbotic (NasdaqGM:SYM) from Outperform ...

In a report released today, William Katz from TD Cowen maintained a Hold rating on Raymond James Financial (RJF – Research Report), with a ...

Raymond James lowered the firm’s price target on Corpay (CPAY) to $417 from $434 and keeps an Outperform rating on the shares. Corpay reported ...